Design of a randomized, placebo-controlled, phase 2 study evaluating the safety and efficacy of tanezumab for treatment of schwannomatosis-related pain
- Resource Type
- Article
- Source
- In
Contemporary Clinical Trials October 2022 121 - Subject
- Language
- ISSN
- 1551-7144